Skip to main content
SpringerLink
Log in

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Morgan JE et al (2017) Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology. Support Care Cancer 25(1):221–228

    Article  Google Scholar 

  2. Brouwers MC et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182(18):E839–E842

    Article  Google Scholar 

  3. Blyth, C.C., T.A. O'Brien, and P. Palasanthiran (2007) Australasian guideline for antifungal therapy in neonates and children with proven, probable and suspected fungal infecti0ons. : http://www.mycology.adelaide.edu.au/virtual/guidelines/

  4. Blyth CC et al (2014) Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 44(12b):1333–1349

    Article  CAS  Google Scholar 

  5. Chang CC et al (2014) Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014. Intern Med J 44(12b):1389–1397

    Article  CAS  Google Scholar 

  6. Chau MM et al (2014) Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J 44(12b):1364–1388

    Article  CAS  Google Scholar 

  7. Chen SC et al (2014) Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J 44(12b):1315–1332

    Article  CAS  Google Scholar 

  8. Cooley L et al (2014) Consensus guidelines for diagnosis, prophylaxis and management of pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Intern Med J 44(12b):1350–1363

    Article  CAS  Google Scholar 

  9. Fleming S et al (2014) Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 44(12b):1283–1297

    Article  CAS  Google Scholar 

  10. Morrissey CO et al (2014) Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J 44(12b):1298–1314

    Article  CAS  Google Scholar 

  11. Slavin MA et al (2014) Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014. Intern Med J 44(12b):1267–1276

    Article  CAS  Google Scholar 

  12. van Hal SJ et al (2014) Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand. Intern Med J 44(12b):1277–1282

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Western Australia, M561, 35 Stirling Highway, Crawley, Perth, WA, Australia

    Christopher C Blyth & Rishi S Kotecha

  2. Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia

    Christopher C Blyth

  3. Department of Infectious Diseases and PathWest Laboratory Medicine, Princess Margaret Hospital for Children, Subiaco, Perth, WA, Australia

    Christopher C Blyth

  4. Paediatric Integrated Cancer Service, Parkville, Melbourne, VIC, Australia

    Gabrielle M Haeusler

  5. Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

    Gabrielle M Haeusler & Monica A Slavin

  6. Department of Infection and Immunity, Monash Children’s Hospital and Department of Paediatrics, Monash University, Clayton, Melbourne, VIC, Australia

    Gabrielle M Haeusler

  7. Department of Immunology and Infectious Diseases, Sydney Children’s Hospital, Randwick, Sydney, NSW, Australia

    Brendan J McMullan

  8. School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW, Australia

    Brendan J McMullan

  9. Department of Clinical Haematology and Oncology, Princess Margaret Hospital for Children, Subiaco, Perth, WA, Australia

    Rishi S Kotecha

  10. Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia

    Rishi S Kotecha

  11. Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia

    Monica A Slavin

  12. Department of Medicine, University of Melbourne, Melbourne, VIC, Australia

    Monica A Slavin

  13. Infection Management Prevention Service, Lady Cilento Children’s Hospital, Brisbane, QLD, Australia

    Julia E Clark

  14. School of Medicine, University of Queensland, Brisbane, QLD, Australia

    Julia E Clark

Authors
  1. Christopher C Blyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabrielle M Haeusler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brendan J McMullan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rishi S Kotecha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monica A Slavin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Julia E Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher C Blyth.

Ethics declarations

Conflicts of interest

Prof Slavin has received investigator initiated funds from Merck and has previously been a member of advisory boards and speakers bureaus for Merck and Gilead Sciences. A/Prof Clark has previously received investigator-initiated research funds from Gilead. No funding was received in the preparation of this manuscript. Human ethics approval nor informed consent was required for this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blyth, C.C., Haeusler, G.M., McMullan, B.J. et al. Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology. Support Care Cancer 25, 3289–3290 (2017). https://doi.org/10.1007/s00520-017-3681-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-017-3681-0

Search

Navigation